The Danish company Lyras A/S has allowed the award-winning Australian food and beverage company Beston Global Food Company the exclusive rights to use Lyras’ sustainable technology for production of lactoferrin and similar products in Australia and New Zealand, for a limited period. Lyras’ technology inactivates bacteria and spores in liquid food by using a technique called Raslysation, which is based on UV-light. This technology reduces energy usage by up to 90% and water usage by up to 60% compared to traditional pasteurisation. Furthermore, it conserves the natural nutritions, structure, and taste of the food due to the gentle treatment.
Said Tina Li, CCO, Beston Global Food Company: “The ability to manufacture Lactoferrin without a form of heat denaturation will be unique within the marketplace. By not subjecting the Lactoferrin to a HTST process will provide Beston with a Lactoferrin product that is in its most natural state, thereby improving the bioavailability and purity of the final product which would make an ideal ingredient for health supplements and pharmaceutical applications.”
The market for lactoferrin has exploded in recent years due to scientific research indicating major health benefits related to the protein. Studies have shown that lactoferrin compliments the human immune system with anti-microbic, antioxidant and anti-carcinogenic properties. This has led to an increase in the use of lactoferrin in infant formula dietary supplements, foods and cosmetics.
Added Leif Brandt Iversen, Senior Sales Manager, Lyras: “Lactoferrin is very heat sensitive losing approximately a third of its activity when heated. For this reason, it is a huge advantage to use our technology, raslysation, instead of traditional pasteurisation. We have other companies showing a lot of interest in this product all around the world as well as in Asia and Oceania.”
Concluded Darren Flew, CEO, Beston Global Food Company: “Beston will continue to work with world leading technology suppliers to develop and market the next generation of lactoferrin products which will be a significant step forward on the current products within the marketplace.” For more visit lyras.com